Novo Nordisk A/S ADR buy Nordea Equity Research
Start price
19.06.26
/
50%
€39.32
Target price
19.06.27
-
Performance (%)
1.48%
Price
06.08.26
€39.90
Summary
This prediction is currently active. With a performance of 1.48%, the BUY prediction by Nordea_Equity_Resear for Novo Nordisk A/S ADR is trending in the right direction. This prediction currently runs until 19.06.27. The prediction end date can be changed by Nordea_Equity_Resear at any time. Nordea_Equity_Resear has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -10.818% | -10.818% |
| iShares Core DAX® | 3.153% | 1.504% |
| iShares Nasdaq 100 | 7.431% | -1.584% |
| iShares Nikkei 225® | 8.571% | -4.324% |
| iShares S&P 500 | 4.578% | 1.920% |
Comments by Nordea_Equity_Resear for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NVO) was upgraded by Nordea Equity Research from "hold" to "buy".
Ratings data for NVO provided by MarketBeat